Active Clinical Trials

Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.

Showing 175 results
  • Sort by
  • Study title
  • Condition
  • Phase
  • Location
Study title Condition Phase Location NCT ID

Fabhalta Capsules Specified Drug-use Survey

 		C3 Glomerulopathy Japan NCT07156149

Real-world Evaluation of Patient Outcomes and Experiences With Ribociclib Early Adopters.

 		Breast Cancer United Kingdom NCT07243002

Leqvio rPMS (Regulatory Post-Marketing Surveillance in Korea)

 		Primary Hypercholesterolemia or Mixed Dyslipidemia South Korea NCT06770543

Study of GVV858 as a Single Agent or in Combination With Endocrine Therapy in Patients With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors

 		Advanced HR+/HER2- Breast Cancer, Advanced CCNE1-amplified Solid Tumors, Metastatic Castration-resistant Prostate Cancer Phase1, Phase2 Singapore NCT07288359

Study Testing the Efficacy, Safety, and Tolerability of EDI048 in Cryptosporidium Infection Model in Healthy Adults

 		Cryptosporidiosis Phase2 United States NCT07249463

A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis

 		Secondary Progressive Multiple Sclerosis (SPMS) Phase3 Australia
Canada
Israel
United States
View all
 NCT07225504

Non-interventional Study to Assess the Effectiveness and Safety of Ribociclib in the Adjuvant Therapy of Hormone Receptor Positive (HR+) HER2-negative Stage II and III Breast Cancer in Real Clinical Practice in Russia

 		Breast Cancer Russia NCT06930859

A Study of DII235 in Adults With Elevated Lipoprotein(a)

 		Lipoprotein Disorder Phase2 Japan
United States 		NCT07235046

Observational Study on Lutetium (177Lu) Vipivotide Tetraxetan to Treat Metastatic Castration Resistant Prostate Cancer

 		Metastatic Castration Resistant Prostate Cancer Italy NCT07093801

Evaluation of 1-Year Clinical Outcomes With Early Inclisiran Initiation in Post-MI Patients

 		Myocardial Infarction Russia NCT07142265